PROMETHEUS LABORATORIES INC.
Clinical Medical Laboratory · SAN DIEGO, CA
Organization Active NPI 1073642641
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,572 | 12,095 | $1,598,665 | $387,040 | $353,081 |
| 2023 | 3,351 | 11,481 | $1,966,305 | $363,665 | $338,932 |
| 2022 | 4,384 | 14,334 | $3,695,045 | $452,464 | $421,280 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 83520 | Measurement of substance using immunoassay technique | 5,029 | $17 | $17 |
| 82542 | Chemical analysis using chromatography technique | 1,457 | $24 | $24 |
| 82397 | Analysis using chemiluminescent technique (light and chemical )reaction | 1,179 | $14 | $14 |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | 641 | $5 | $5 |
| 88346 | Antibody evaluation, initial single antibody stain procedure | 554 | $136 | $102 |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | 552 | $130 | $103 |
| 80230 | Measurement of infliximab | 495 | $38 | $38 |
| 80280 | Measurement of vedolizumab | 391 | $38 | $38 |
| 81382 | Hla class ii typing high resolution one locus | 346 | $121 | $121 |
| 86258 | Detection of gliadin (deamidated) (dgp) antibody | 272 | $12 | $12 |
| 80145 | Measurement of adalimumab | 219 | $38 | $38 |
| 83883 | Nephelometry, test method using light | 210 | $13 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Clinical Medical Laboratory | 291U00000X | ✓ | 05D0917432 | CA |
| Clinical Medical Laboratory | 291U00000X | — | — |
Other Clinical Medical Laboratory providers in California
- NPI 1104109453
- NPI 1417608472
- NPI 1407178650
- NPI 1255656153
- NPI 1598098238
- NPI 1528490240
- NPI 1235703232
- NPI 1386708816
See all Clinical Medical Laboratory providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.